Essential Reviews in Geriatric Psychiatry

This book critically reviews 75 important published papers that influence the practice of geriatric psychiatry. This book will assist anyone who is interested in the care of older adults with psychiatric disorders. It was written by thought leaders who shape the way geriatric psychiatry is currently practiced in the United States. All the major psychiatric disorders in later life are covered including anxiety disorders, bipolar disorders, depressive disorders, neurocognitive disorders, psychotic disorders, sleep disorders, and substance use disorders. It also reviews important studies on suicides in late life and interventional procedures in geriatric psychiatry like the ECT, and also evaluates the adverse effects of psychotropic medications on older adults with psychiatric disorders.

The editors of the book along with input from members of the teaching and training committee of the American Association for Geriatric Psychiatry (AAGP) have chosen 75 published papers from the field of geriatric psychiatry that they believe provides the highest knowledge-yield/impact for practicing clinicians and educators in the field of geriatric mental health. The AAGP is a national association that represents and serves its members and the field of geriatric psychiatry. These 75 papers are critically appraised by the members of AAGP using a standardized format and a summary of these papers and their practical application is provided by these experts. This information can be used by anyone who wants to learn about the field of geriatric psychiatry.

Written by experts in the field of geriatric psychiatry Reviews studies on late life suicide and interventional proceducres in geriatric psychiatry Each chapter review provides a summary, conclusions, strengths and limitations

Autorentext

Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP, Creighton University School of Medicine, Department of Psychiatry, Creighton, NE

Dr. Tampi is the Professor and Chairman of the Department of Psychiatry at Creighton University School of Medicine, Omaha, Nebraska. He is also the Chairman of Catholic Health Initiatives (CHI) Behavioral Health Services, Omaha, Nebraska. Dr. Tampi maintains his appointment as an Adjunct Professor of Psychiatry at Yale School of Medicine, New Haven, Connecticut. He is a Past President of the American Association for Geriatric Psychiatry (AAGP).

Deena J. Tampi, MSN, MBA-HCA, RN, DFAAGP, Behavioral Health Advisory Group, Princeton, NJ, USA

Ms. Tampi is the Co-Founder and Managing Principal, Behavioral Health Advisory Group, Princeton, New Jersey. Ms. Tampi is on the Board of Directors for the American Association for Geriatric Psychiatry. In addition, she is the Chairperson of the Membership Committee for the American Association for Geriatric Psychiatry.

Juan J. Young, MD, Yale School of Medicine, Geriatric Psychiatry, New Haven, CT

Dr. Young is a current Geriatric Psychiatry Fellow at the Yale School of Medicine, and he also serves in the AAGP Membership Committee.

Meera Balasubramaniam, MD, MPH, NYU Langone Health, Department of Psychiatry, New York, NY

Dr. Meera Balasubramaniam is a Clinical Assistant Professor and the Director of the Geriatric Psychiatry fellowship program at the New York University School of Medicine. She has served on the editorial board of Frontiers in Psychiatry, is an Associate member on the editorial board of the American Journal of Geriatric Psychiatry

Pallavi Joshi, DO, MA University of Arizona College of Medicine-Phoenix, Phoenix, AZ

Dr. Pallavi Joshi is a Clinical Assistant Professor at University of Arizona College of Medicine-Phoenix and a geriatricpsychiatrist at Banner Alzheimer's Institute. She has served on the Board of Directors for the American Association for Geriatric Psychiatry and the Council of Geriatric Psychiatry for the American Psychiatric Association.

Inhalt
Section 1: Adverse effects of medications.- Do atypical antipsychotics cause stroke?.- Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.- Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons.- The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.- Do antipsychotics lead to cognitive impairment in dementia? A meta-analysis of randomised placebo-controlled trials.- A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias.- Section 2: Anxiety Disorders.- Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.- Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results froman 8-week randomized, placebo-controlled trial.- Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.- Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.- Meta-analysis Comparing Different Behavioral Treatments for Late-Life Anxiety.- Cognitive Behavior Therapy for Generalized Anxiety Disorder Among Older Adults in Primary Care: A Randomized Clinical Trial.- Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial.- A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder.- Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults.- A meta-analysis of cognitive functioning in older adults with PTSD.- Anxiety as a Predictor for Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis.- Section 3: Bipolar Disorder.- A Pilot Study of Standardized Treatment in Geriatric Bipolar Disorder.- Differences in clinical features and mental health service use in bipolar disorder across the lifespan.- Effect of antidepressant use on admissions to hospital among elderly bipolar patients.- GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.- History of Bipolar disorder and the risk of dementia: A systematic review and meta-analysis.- Section 4. Delirium.- A Multicomponent Intervention to Prevent Delirium in Hospitalized Older Patients.- Delirium in elderly patients and the risk of post discharge mortality, institutionalization, and dementia: a meta-analysis.- Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis.- Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis.- Interventions for preventing delirium in older people in institutional longterm care.- Section 5: Depressive Disorders.- Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression. A Randomized Controlled Trial in Patients Older Than 59 Years.- Continuation treatment of delusional depression in older adults.- Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.- Remission in Depressed Geriatric Primary Care Patients: A Report from the PROSPECT Study.- Executive dysfunction and the course of geriatric depression.- Maintenance Treatment of Major Depression in Old Age.- Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression.- Efficacy of Second-Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence.- A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).- Speed of remis…